BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35913830)

  • 1. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
    Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
    Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Anterior Resection Syndrome After Transanal Total Mesorectal Excision: A Comparison With the Conventional Top-to-Bottom Approach.
    Foo CC; Kin Ng K; Tsang JS; Siu-Hung Lo O; Wei R; Yip J; Lun Law W
    Dis Colon Rectum; 2020 Apr; 63(4):497-503. PubMed ID: 32015290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.
    de Lacy FB; Turrado-Rodriguez V; Torroella A; van Laarhoven J; Otero-PiƱeiro A; Almenara R; Lacima G; Castells A; Lacy AM
    Dis Colon Rectum; 2022 Jan; 65(1):46-54. PubMed ID: 34596984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life and Functional Outcomes After Intersphincteric Resection for Ultralow Rectal Cancer: A Prospective Observational Study.
    Zhang B; Zhuo GZ; Zhao Y; Zhao YJ; Zhu J; Liu FF; Ding JH
    Dis Colon Rectum; 2023 Jul; 66(7):1029-1038. PubMed ID: 36602458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
    Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
    Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal Total Mesorectal Excision in Mid-Low Rectal Cancer: Evaluation of the Learning Curve and Comparison of Short-term Results With Standard Laparoscopic Total Mesorectal Excision.
    Zeng Z; Liu Z; Huang L; Liu H; Jie H; Luo S; Zhang X; Kang L
    Dis Colon Rectum; 2021 Apr; 64(4):380-388. PubMed ID: 33394779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
    Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
    Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
    Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
    Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior Resection Syndrome and Quality of Life With Long-term Follow-up After Rectal Cancer Resection.
    Dilke SM; Hadjittofi C; Than M; Tozer PJ; Stearns AT;
    Dis Colon Rectum; 2022 Oct; 65(10):1251-1263. PubMed ID: 34840295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Outcomes and Quality of Life after Redo Anastomosis in Patients With Rectal Cancer: An International Multicenter Comparative Cohort Study.
    Westerduin E; Elfeki H; Frontali A; Lakkis Z; Laurberg S; Tanis PJ; Wolthuis AM; Panis Y; D'Hoore A; Bemelman WA; Juul T
    Dis Colon Rectum; 2021 Jul; 64(7):822-832. PubMed ID: 33902088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
    Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
    Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robot-Assisted Total Mesorectal Excision Versus Laparoscopic Total Mesorectal Excision: A Retrospective Propensity Score-Matched Cohort Analysis in Experienced Centers.
    Burghgraef TA; Crolla RMPH; Verheijen PM; Fahim M; van Geloven A; Leijtens JWA; Pronk A; Smits AB; Verdaasdonk EGG; Consten ECJ
    Dis Colon Rectum; 2022 Feb; 65(2):218-227. PubMed ID: 34459449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.